Rapid and sustained response to Chimeric Antigen Receptor T cell therapy in double hit diffuse large B cell lymphoma

Am J Hematol. 2020 Mar;95(3):333-334. doi: 10.1002/ajh.25621. Epub 2019 Sep 9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Head and Neck Neoplasms* / diagnostic imaging
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Immunotherapy, Adoptive*
  • Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Middle Aged
  • Prednisone / administration & dosage
  • Receptors, Chimeric Antigen / therapeutic use*
  • Rituximab / administration & dosage
  • Vincristine / administration & dosage

Substances

  • R-CHOP protocol
  • Receptors, Chimeric Antigen
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone